[1]
A. Tsumura, D. Looi, B. N. Moskoff, J. M. Tuscano, and N. Esteghamat, “Outcomes of Gemcitabine, Vinorelbine, and Doxorubicin in Peripheral T-Cell Lymphoma”, acmcr, vol. 8, no. 3, pp. 92–96, May 2024.